Liposomal vs. Conventional Bupivacaine for Pain Control
Status:
COMPLETED
Trial end date:
2024-10-14
Target enrollment:
Participant gender:
Summary
The goal of this pilot study is to test the hypothesis that liposomal bupivacaine extends the duration of paravertebral block in patients undergoing radical nephrectomy, achieving improved analgesia compared to conventional bupivacaine. The main questions it aims to answer are:
* Area under curve of numeric rating scale of pain from 12 to 72 h after surgery.
* Cumulative opioid consumption during the period of 12 to 72 h after surgery.